137 related articles for article (PubMed ID: 12684658)
1. Chromosomal imbalance maps of human 5FU-resistant colorectal cancer cell lines: implications in the analysis of 5FU-acquired resistance mechanisms.
Plasencia C; Rooney PH; Taron M; Martinez-Balibrea E; McLeod HL; Abad A
Int J Oncol; 2003 May; 22(5):945-53. PubMed ID: 12684658
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative effects of ZD0473 (AMD473) in combination with 5-fluorouracil or SN38 in human colorectal cancer cell lines.
Plasencia C; Abad A; Martinez-Balibrea E; Taron M
Invest New Drugs; 2004 Nov; 22(4):399-409. PubMed ID: 15292710
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal imbalances associated with acquired resistance to fluoropyrimidines in human colorectal cancer cells.
Hidaka S; Yasutake T; Fukushima M; Yano H; Haseba M; Tsuji T; Sawai T; Yamaguchi H; Nakagoe T; Ayabe H; Tagawa Y
Eur J Cancer; 2003 May; 39(7):975-80. PubMed ID: 12706367
[TBL] [Abstract][Full Text] [Related]
4. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
[TBL] [Abstract][Full Text] [Related]
5. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism.
Peters GJ; Backus HH; Freemantle S; van Triest B; Codacci-Pisanelli G; van der Wilt CL; Smid K; Lunec J; Calvert AH; Marsh S; McLeod HL; Bloemena E; Meijer S; Jansen G; van Groeningen CJ; Pinedo HM
Biochim Biophys Acta; 2002 Jul; 1587(2-3):194-205. PubMed ID: 12084461
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines.
Suetsugu T; Mori R; Futamura M; Fukada M; Tanaka H; Yasufuku I; Sato Y; Iwata Y; Imai T; Imai H; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yoshida K
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649846
[TBL] [Abstract][Full Text] [Related]
7. Cerivastatin enhances the cytotoxicity of 5-fluorouracil on chemosensitive and resistant colorectal cancer cell lines.
Wang W; Collie-Duguid E; Cassidy J
FEBS Lett; 2002 Nov; 531(3):415-20. PubMed ID: 12435585
[TBL] [Abstract][Full Text] [Related]
8. Role of genomic factors beyond thymidylate synthase in the prediction of response to 5-fluorouracil.
Peters GJ; Smid K; Meijer E; van Groeningen CJ; Leon LG
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):595-603. PubMed ID: 27906628
[TBL] [Abstract][Full Text] [Related]
9. Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy.
Brody JR; Hucl T; Gallmeier E; Winter JM; Kern SE; Murphy KM
Cancer Res; 2006 Oct; 66(19):9369-73. PubMed ID: 17018589
[TBL] [Abstract][Full Text] [Related]
10. APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling.
Petty RD; Samuel LM; Murray GI; MacDonald G; O'Kelly T; Loudon M; Binnie N; Aly E; McKinlay A; Wang W; Gilbert F; Semple S; Collie-Duguid ES
BMC Cancer; 2009 Dec; 9():434. PubMed ID: 20003335
[TBL] [Abstract][Full Text] [Related]
11. Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma.
Wong NA; Brett L; Stewart M; Leitch A; Longley DB; Dunlop MG; Johnston PG; Lessells AM; Jodrell DI
Br J Cancer; 2001 Dec; 85(12):1937-43. PubMed ID: 11747337
[TBL] [Abstract][Full Text] [Related]
12. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
[TBL] [Abstract][Full Text] [Related]
13. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis.
Ghosh S; Singh R; Vanwinkle ZM; Guo H; Vemula PK; Goel A; Haribabu B; Jala VR
Theranostics; 2022; 12(12):5574-5595. PubMed ID: 35910798
[TBL] [Abstract][Full Text] [Related]
14. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
[TBL] [Abstract][Full Text] [Related]
15. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer.
Zhao Y; Wang C; Goel A
Carcinogenesis; 2021 Jun; 42(6):814-825. PubMed ID: 33822896
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization analysis of chromosomal alterations induced by the development of resistance to thymidylate synthase inhibitors.
Rooney PH; Stevenson DA; Marsh S; Johnston PG; Haites NE; Cassidy J; McLeod HL
Cancer Res; 1998 Nov; 58(22):5042-5. PubMed ID: 9823306
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors.
Kadota K; Huang CL; Liu D; Yokomise H; Haba R; Wada H
Int J Oncol; 2011 Feb; 38(2):355-63. PubMed ID: 21174056
[TBL] [Abstract][Full Text] [Related]
18. Combination studies of antifolates with 5-fluorouracil in colon cancer cell lines.
van der Wilt CL; Kuiper CM; Peters GJ
Oncol Res; 1999; 11(8):383-91. PubMed ID: 10803742
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase.
Nakamura A; Nakajima G; Okuyama R; Kuramochi H; Kondoh Y; Kanemura T; Takechi T; Yamamoto M; Hayashi K
Gastric Cancer; 2014 Jan; 17(1):188-95. PubMed ID: 23494117
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes.
De Angelis PM; Clausen OP; Schjølberg A; Stokke T
Br J Cancer; 1999 May; 80(3-4):526-35. PubMed ID: 10408863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
